| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sequent Scientific Limited (NSE: SEQUENT)
SEQUENT Technical Analysis
1.5
| As on 25th Apr 2024 SEQUENT SHARE Price closed @ 124.95 and we RECOMMEND Buy for LONG-TERM with Stoploss of 106.91 & Sell for SHORT-TERM with Stoploss of 128.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SEQUENTSHARE Price
| Open | 126.05 | Change | Price | % |
| High | 126.50 | 1 Day | -1.10 | -0.87 |
| Low | 124.00 | 1 Week | 5.65 | 4.74 |
| Close | 124.95 | 1 Month | 8.55 | 7.35 |
| Volume | 430051 | 1 Year | 49.60 | 65.83 |
| 52 Week High 152.70 | 52 Week Low 62.25 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| SEQUENT Daily Charts |
SEQUENT Intraday Charts |
Whats New @ Bazaartrend |
SEQUENT Free Analysis |
|
|
SEQUENT Important Levels Intraday
| RESISTANCE | 129.77 |
| RESISTANCE | 128.22 |
| RESISTANCE | 127.27 |
| RESISTANCE | 126.31 |
| SUPPORT | 123.59 |
| SUPPORT | 122.63 |
| SUPPORT | 121.68 |
| SUPPORT | 120.13 |
SEQUENT Target April 2024
| 4th UP Target | 196.59 |
| 3rd UP Target | 175.33 |
| 2nd UP Target | 162.19 |
| 1st UP Target | 149.05 |
| 1st DOWN Target | 111.55 |
| 2nd DOWN Target | 98.41 |
| 3rd DOWN Target | 85.27 |
| 4th DOWN Target | 64.01 |
SEQUENT Weekly Target
| 4th UP Target | 148.31 |
| 3rd UP Target | 139.07 |
| 2nd UP Target | 133.36 |
| 1st UP Target | 127.65 |
| 1st DOWN Target | 111.35 |
| 2nd DOWN Target | 105.64 |
| 3rd DOWN Target | 99.93 |
| 4th DOWN Target | 90.69 |
SEQUENT Target2024
| 4th UP Target | 242.67 |
| 3rd UP Target | 201.32 |
| 2nd UP Target | 175.77 |
| 1st UP Target | 150.21 |
| 1st DOWN Target | 77.29 |
| 2nd DOWN Target | 51.73 |
| 3rd DOWN Target | 26.18 |
| 4th DOWN Target | -15.17 |
Sequent Scientific Limited ( NSE INDIA Symbol : SEQUENT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SEQUENT Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 73.23 | |
| 10 Day Avg Volume | Traded 58.37 % More then 10 Day Average Volume | ||
SEQUENT Other Details
| Segment | EQ | |
| Market Capital | 50618011648.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
SEQUENT Address
 |
||
SEQUENT Latest News
SEQUENT Business Profile
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments. Address: Dosti Pinnacle, Mumbai, India, 400604
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service